BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 9285545)

  • 21. De novo thrombotic microangiopathy in renal transplant recipients: a comparison of hemolytic uremic syndrome with localized renal thrombotic microangiopathy.
    Schwimmer J; Nadasdy TA; Spitalnik PF; Kaplan KL; Zand MS
    Am J Kidney Dis; 2003 Feb; 41(2):471-9. PubMed ID: 12552512
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thrombotic thrombocytopenic purpura-like syndromes following bone marrow transplantation: an analysis of associated conditions and clinical outcomes.
    Roy V; Rizvi MA; Vesely SK; George JN
    Bone Marrow Transplant; 2001 Mar; 27(6):641-6. PubMed ID: 11319595
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Heparin-induced thrombocytopenia antibody and the pathogenesis of thrombotic microangiopathy after stem cell transplantation.
    Takatsuka H; Nakajima T; Nomura K; Wakae T; Toda A; Itoi H; Okada M; Misawa M; Hara H
    Clin Transplant; 2005 Jun; 19(3):418-22. PubMed ID: 15877808
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk factor analysis for thrombotic microangiopathy after reduced-intensity or myeloablative allogeneic hematopoietic stem cell transplantation.
    Nakamae H; Yamane T; Hasegawa T; Nakamae M; Terada Y; Hagihara K; Ohta K; Hino M
    Am J Hematol; 2006 Jul; 81(7):525-31. PubMed ID: 16755559
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of splenic irradiation in patients with chronic myeloid leukemia undergoing allogeneic bone marrow transplantation.
    Jabro G; Koc Y; Boyle T; Schenkein DP; Ravalese J; Wazer D; Miller KB
    Biol Blood Marrow Transplant; 1999; 5(3):173-9. PubMed ID: 10392963
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Posttransplant thrombotic microangiopathy: sensitivity of proposed new diagnostic criteria.
    Kennedy GA; Bleakley S; Butler J; Mudie K; Kearey N; Durrant S
    Transfusion; 2009 Sep; 49(9):1884-9. PubMed ID: 19453982
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thrombotic microangiopathy associated with reactivation of human herpesvirus-6 following high-dose chemotherapy with autologous bone marrow transplantation in young children.
    Matsuda Y; Hara J; Miyoshi H; Osugi Y; Fujisaki H; Takai K; Ohta H; Tanaka-Taya K; Yamanishi K; Okada S
    Bone Marrow Transplant; 1999 Oct; 24(8):919-23. PubMed ID: 10516706
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Booster marrow or blood cells for graft failure after allogeneic bone marrow transplantation.
    Remberger M; Ringdén O; Ljungman P; Hägglund H; Winiarski J; Lönnqvist B; Aschan J
    Bone Marrow Transplant; 1998 Jul; 22(1):73-8. PubMed ID: 9678799
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Red cell fragmentation (schistocytosis) after bone marrow transplantation.
    Zomas A; Saso R; Powles R; Mackay H; Singhal S; Treleaven J; Mehta J
    Bone Marrow Transplant; 1998 Oct; 22(8):777-80. PubMed ID: 9827975
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thrombotic microangiopathy in blood and marrow transplant patients receiving tacrolimus or cyclosporine A.
    Sarkodee-Adoo C; Sotirescu D; Sensenbrenner L; Rapoport AP; Cottler-Fox M; Tricot G; Ruehle K; Meisenberg B
    Transfusion; 2003 Jan; 43(1):78-84. PubMed ID: 12519434
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Treatment of thrombotic microangiopathies].
    Debourdeau P; Zammit C; Souleau B; Védrine L; Farge-Bancel D
    Ann Med Interne (Paris); 1999 Sep; 150(5):374-87. PubMed ID: 10544747
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transplant-associated microangiopathy in patients receiving tacrolimus following allogeneic stem cell transplantation: risk factors and response to treatment.
    Oran B; Donato M; Aleman A; Hosing C; Korbling M; Detry MA; Wei C; Anderlini P; Popat U; Shpall E; Giralt S; Champlin RE
    Biol Blood Marrow Transplant; 2007 Apr; 13(4):469-77. PubMed ID: 17382253
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Causes of acute thrombotic microangiopathy in patients receiving kidney transplantation.
    Jumani A; Hala K; Tahir S; Al-Ghamdi G; Al-Flaiw A; Hejaili F; Qureshi J; Raza H; Ghalib M; Khader AA
    Exp Clin Transplant; 2004 Dec; 2(2):268-72. PubMed ID: 15859940
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnostic value of hemostatic parameters in bone marrow transplant-associated thrombotic microangiopathy.
    Kanamori H; Maruta A; Sasaki S; Yamazaki E; Ueda S; Katoh K; Tamura T; Otsuka-Aoba M; Taguchi J; Harano H; Ogawa K; Mohri H; Okubo T; Matsuzaki M; Watanabe S; Koharazawa H; Fujita H; Kodama F
    Bone Marrow Transplant; 1998 Apr; 21(7):705-9. PubMed ID: 9578311
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thrombotic thrombocytopenic purpura induced by cyclosporin a after allogeneic bone marrow transplantation treated by red blood cell exchange transfusion: a case report.
    Gupta S; Ttan N; Topolsky D; Sesok-Pizzini D; Crilley P; Balasubramanian M; Kahn SB; Brodsky I; Ward K; Styler M
    Am J Hematol; 2005 Nov; 80(3):246-7. PubMed ID: 16247749
    [No Abstract]   [Full Text] [Related]  

  • 36. Lymphoproliferative disorders following allogeneic bone marrow transplantation: the Vancouver experience.
    Micallef IN; Chhanabhai M; Gascoyne RD; Shepherd JD; Fung HC; Nantel SH; Toze CL; Klingemann HG; Sutherland HJ; Hogge DE; Nevill TJ; Le A; Barnett MJ
    Bone Marrow Transplant; 1998 Nov; 22(10):981-7. PubMed ID: 9849695
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thrombotic microangiopathy after allogeneic hematopoietic stem cell transplantation: an autopsy study.
    Siami K; Kojouri K; Swisher KK; Selby GB; George JN; Laszik ZG
    Transplantation; 2008 Jan; 85(1):22-8. PubMed ID: 18192907
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cyclosporine-associated thrombotic microangiopathy: report of two cases with good outcome and successful subsequent reuse.
    Dhib M; Moulin B; Abderrahim E; Etienne I; Godin M; Fillastre JP
    Transplant Proc; 1993 Jun; 25(3):2294-6. PubMed ID: 8516905
    [No Abstract]   [Full Text] [Related]  

  • 39. [Fulminant angiopathy caused by allogenic transplantation of bone marrow with cerebral involvement: clinico-pathologic correlation].
    Guerrero AL; Pérez-Simón JA; Cuñado A; Cacho J; Vidriales B
    An Med Interna; 1998 Oct; 15(10):545-7. PubMed ID: 9844232
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Bone marrow transplantation-associated thrombotic microangiopathy manifested by visual disturbance].
    Nakai K; Tajima K; Kishimoto Y; Katsura K; Kawamura M; Yamamoto Y; Hanada M; Zen K; Amakawa R; Fujimoto M; Fukuhara S
    Rinsho Ketsueki; 2000 Jan; 41(1):25-31. PubMed ID: 10695395
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.